DCM Shriram Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 23, 2025, 11:00 am

Quick Insight

DCM Shriram Industries Ltd, operating in the sugar industry, currently trades at a price of 169 with a market capitalization of 1,470 crore. With a P/E ratio of 16.9, ROE at 11.8%, and ROCE at 13.7%, the company demonstrates moderate profitability. Its OPM stands at 10%, yielding a net profit of 101 crore. The company has a healthy mix of shareholding, with promoters holding a majority stake at 50.11%. However, the company's borrowing stands at 534 crore against reserves of 882 crore, indicating a reliance on debt financing. Overall, investors should closely monitor the company's debt levels and operational efficiency to assess future growth prospects.

Competitors of DCM Shriram Industries Ltd

All Competitor Stocks of DCM Shriram Industries Ltd

Quarterly Result

Last Updated: August 19, 2025, 8:25 pm

Below is a detailed analysis of the quarterly data for DCM Shriram Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 499.00 Cr.. The value appears strong and on an upward trend. It has increased from 472.00 Cr. (Mar 2025) to 499.00 Cr., marking an increase of 27.00 Cr..
• For Expenses, as of Jun 2025, the value is 455.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 423.00 Cr. (Mar 2025) to 455.00 Cr., marking an increase of 32.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 44.00 Cr.. The value appears to be declining and may need further review. It has decreased from 48.00 Cr. (Mar 2025) to 44.00 Cr., marking a decrease of 4.00 Cr..
• For OPM %, as of Jun 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Mar 2025) to 9.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 11.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2025) to 26.00 Cr., marking a decrease of 10.00 Cr..
• For Tax %, as of Jun 2025, the value is 36.00%. The value appears to be increasing, which may not be favorable. It has increased from 35.00% (Mar 2025) to 36.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Mar 2025) to 17.00 Cr., marking a decrease of 7.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.94. The value appears to be declining and may need further review. It has decreased from 2.72 (Mar 2025) to 1.94, marking a decrease of 0.78.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:57 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:28 pm

Below is a detailed analysis of the balance sheet data for DCM Shriram Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 17.00 Cr..
• For Reserves, as of Mar 2025, the value is 882.00 Cr.. The value appears strong and on an upward trend. It has increased from 798.00 Cr. (Mar 2024) to 882.00 Cr., marking an increase of 84.00 Cr..
• For Borrowings, as of Mar 2025, the value is 534.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 529.00 Cr. (Mar 2024) to 534.00 Cr., marking an increase of 5.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 878.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 855.00 Cr. (Mar 2024) to 878.00 Cr., marking an increase of 23.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,311.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,199.00 Cr. (Mar 2024) to 2,311.00 Cr., marking an increase of 112.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 662.00 Cr.. The value appears strong and on an upward trend. It has increased from 627.00 Cr. (Mar 2024) to 662.00 Cr., marking an increase of 35.00 Cr..
• For CWIP, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 51.00 Cr. (Mar 2024) to 47.00 Cr., marking a decrease of 4.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,599.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,514.00 Cr. (Mar 2024) to 1,599.00 Cr., marking an increase of 85.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,311.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,199.00 Cr. (Mar 2024) to 2,311.00 Cr., marking an increase of 112.00 Cr..

Notably, the Reserves (882.00 Cr.) exceed the Borrowings (534.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for DCM Shriram Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 11.66. This value is within the healthy range. It has decreased from 13.27 (Mar 24) to 11.66, marking a decrease of 1.61.
• For Diluted EPS (Rs.), as of Mar 25, the value is 11.66. This value is within the healthy range. It has decreased from 13.27 (Mar 24) to 11.66, marking a decrease of 1.61.
• For Cash EPS (Rs.), as of Mar 25, the value is 16.13. This value is within the healthy range. It has decreased from 17.71 (Mar 24) to 16.13, marking a decrease of 1.58.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 103.33. It has increased from 93.73 (Mar 24) to 103.33, marking an increase of 9.60.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 103.33. It has increased from 93.73 (Mar 24) to 103.33, marking an increase of 9.60.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 235.81. It has decreased from 239.44 (Mar 24) to 235.81, marking a decrease of 3.63.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 26.49. This value is within the healthy range. It has decreased from 28.40 (Mar 24) to 26.49, marking a decrease of 1.91.
• For PBIT / Share (Rs.), as of Mar 25, the value is 21.88. This value is within the healthy range. It has decreased from 23.92 (Mar 24) to 21.88, marking a decrease of 2.04.
• For PBT / Share (Rs.), as of Mar 25, the value is 17.81. This value is within the healthy range. It has decreased from 19.81 (Mar 24) to 17.81, marking a decrease of 2.00.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 11.52. This value is within the healthy range. It has decreased from 13.24 (Mar 24) to 11.52, marking a decrease of 1.72.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.66. This value is within the healthy range. It has decreased from 13.27 (Mar 24) to 11.66, marking a decrease of 1.61.
• For PBDIT Margin (%), as of Mar 25, the value is 11.23. This value is within the healthy range. It has decreased from 11.85 (Mar 24) to 11.23, marking a decrease of 0.62.
• For PBIT Margin (%), as of Mar 25, the value is 9.27. This value is below the healthy minimum of 10. It has decreased from 9.99 (Mar 24) to 9.27, marking a decrease of 0.72.
• For PBT Margin (%), as of Mar 25, the value is 7.55. This value is below the healthy minimum of 10. It has decreased from 8.27 (Mar 24) to 7.55, marking a decrease of 0.72.
• For Net Profit Margin (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 5. It has decreased from 5.52 (Mar 24) to 4.88, marking a decrease of 0.64.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.94. This value is below the healthy minimum of 8. It has decreased from 5.54 (Mar 24) to 4.94, marking a decrease of 0.60.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.28. This value is below the healthy minimum of 15. It has decreased from 14.15 (Mar 24) to 11.28, marking a decrease of 2.87.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.06. This value is within the healthy range. It has decreased from 20.60 (Mar 24) to 17.06, marking a decrease of 3.54.
• For Return On Assets (%), as of Mar 25, the value is 4.39. This value is below the healthy minimum of 5. It has decreased from 5.24 (Mar 24) to 4.39, marking a decrease of 0.85.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has decreased from 0.62 (Mar 24) to 0.58, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.90. It has decreased from 1.00 (Mar 24) to 0.90, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 1.28. This value is below the healthy minimum of 1.5. It has increased from 1.22 (Mar 24) to 1.28, marking an increase of 0.06.
• For Quick Ratio (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has increased from 0.60 (Mar 24) to 0.62, marking an increase of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.63. This value is below the healthy minimum of 4. It has decreased from 1.90 (Mar 24) to 1.63, marking a decrease of 0.27.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 15.07 (Mar 24) to 0.00, marking a decrease of 15.07.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 11.27 (Mar 24) to 0.00, marking a decrease of 11.27.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 84.93 (Mar 24) to 0.00, marking a decrease of 84.93.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 88.73 (Mar 24) to 0.00, marking a decrease of 88.73.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.50. This value is within the healthy range. It has decreased from 6.91 (Mar 24) to 6.50, marking a decrease of 0.41.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.83. This value is within the healthy range. It has decreased from 4.22 (Mar 24) to 3.83, marking a decrease of 0.39.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,838.21. It has decreased from 2,074.06 (Mar 24) to 1,838.21, marking a decrease of 235.85.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 1. It has decreased from 0.99 (Mar 24) to 0.89, marking a decrease of 0.10.
• For EV / EBITDA (X), as of Mar 25, the value is 7.98. This value is within the healthy range. It has decreased from 8.40 (Mar 24) to 7.98, marking a decrease of 0.42.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.76 (Mar 24) to 0.67, marking a decrease of 0.09.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 84.92 (Mar 24) to 0.00, marking a decrease of 84.92.
• For Price / BV (X), as of Mar 25, the value is 1.54. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.54, marking a decrease of 0.41.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.76 (Mar 24) to 0.67, marking a decrease of 0.09.
• For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.07.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness